Glenmark and Helsinn Group to Anti-Nausea Drug in India and Nepal
2026-10-08
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
-
India Terminates Anti-Dumping Investigation on Chinese Siloxane Polyoxyalkylene Copolymers
-
INEOS Plant Closures Deepen Europe’s Chemical Industry Crisis
-
Dow Chemical’s Freeport Plant Fire Contained; No Injuries Reported
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
Dow Europe Raises Polyurethane Prices in EMEA and India
-
BASF-Evonik Takeover Faces Political Resistance as German State Defends Jobs and Independence
-
$1.35 Billion! AkzoNobel to Sell Decorative Paints Business in Southeast Asia and Australia to Nippon Paint
-
Sinopec and CNAF to Implement Restructuring
Recommend Reading
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Nylon Giant to Close Another European Plant, Cutting 140 Jobs
-
Unilever Reports Stronger Margins and Accelerated Portfolio Transformation in FY2025
-
Isopropanol vs. Isopropyl Alcohol: Are They Different? (Uses & Safety)
-
FDA Revokes Orange B Authorization and Proposes Removing Citrus Red No. 2
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
India Approves ₹30.3 Billion Chemical-Park Scheme to Build Three Mega Industrial Hubs
-
EFSA’s Updated Food-Additive Application Guidance Takes Effect
-
Geopolitical Risks Recede, Dealing a Heavy Blow to the Oil Market; Short-Term Easing Does Not Alter Supply Constraints